Nurix Therapeutics, Inc. (NRIX)
USD 20.24
(-4.44%)
USD 20.24
(-4.44%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -81.36 Million | -159.8 Million | -84.36 Million | -80 Thousand | 601 Thousand | -31.67 Million |
| Net Income | -143.94 Million | -180.36 Million | -117.19 Million | -43.24 Million | -21.69 Million | -9.42 Million |
| Depreciation & Amortization | 13.65 Million | 10.8 Million | 6.08 Million | 2.18 Million | 2.35 Million | 2.98 Million |
| Deferred income taxes | -59.36 Million | - | - | - | - | -354 Thousand |
| Stock-based compensation | 33.67 Million | 28.13 Million | 15.8 Million | 4.3 Million | 510 Thousand | 431 Thousand |
| Change in working capital | 20.12 Million | -19.02 Million | 9.11 Million | 36.4 Million | 19.54 Million | -25.3 Million |
| Other non-cash items | 54.5 Million | 636 Thousand | 1.83 Million | 273 Thousand | -109 Thousand | -6000.00 |
| Investing Cash Flow | 68.3 Million | 27.19 Million | -108.25 Million | -254.4 Million | 8.49 Million | 39.99 Million |
| Investments in PPE | -8.4 Million | -12.24 Million | -5.66 Million | -4.55 Million | -1.65 Million | -1.59 Million |
| Acquisitions | -76.7 Million | -39.44 Million | 102.59 Million | 249.85 Million | -10.14 Million | 6000.00 |
| Investment purchases | -246.33 Million | -239.36 Million | -348.49 Million | -275.22 Million | -9.35 Million | -12.91 Million |
| Sales/Maturities of investments | 323.03 Million | 278.8 Million | 245.9 Million | 25.37 Million | 19.5 Million | 54.5 Million |
| Other Investing Activities | 76.7 Million | 39.44 Million | -102.59 Million | -249.85 Million | 10.14 Million | 6000.00 |
| Financing Cash Flow | 3.21 Million | 117.19 Million | 153.88 Million | 339.02 Million | 126 Thousand | 529 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -1000.00 | -7000.00 | -16 Thousand | -2000.00 |
| Common Stock Issuance | 3.21 Million | 117.19 Million | 150.15 Million | 339.03 Million | 142 Thousand | 531 Thousand |
| Other Financing Activities | 3.21 Million | 117.19 Million | 3.72 Million | 339.02 Million | -16 Thousand | 529 Thousand |
| Accounts receivables | - | 6 Million | -6 Million | -11.34 Million | - | 12.37 Million |
| Accounts payables | 1.61 Million | 85 Thousand | 1.58 Million | 1.23 Million | 302 Thousand | -519 Thousand |
| Inventory | - | - | 6.77 Million | 11.34 Million | - | - |
| Other working capital | 18.5 Million | -25.1 Million | 6.75 Million | 35.17 Million | 19.24 Million | -24.78 Million |
| Cash at beginning of period | 64.47 Million | 80.79 Million | 119.52 Million | 34.98 Million | 25.76 Million | 16.91 Million |
| Cash at end of period | 54.62 Million | 65.37 Million | 80.79 Million | 119.52 Million | 34.98 Million | 25.76 Million |
| Capital Expenditure | -8.4 Million | -12.24 Million | -5.66 Million | -4.55 Million | -1.65 Million | -1.59 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -9.84 Million | -15.41 Million | -38.73 Million | 84.54 Million | 9.22 Million | 8.84 Million |
| Free Cash Flow | -89.76 Million | -172.05 Million | -90.02 Million | -4.63 Million | -1.05 Million | -33.27 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -48.95 Million | -44.54 Million | -41.51 Million | -41.95 Million | -143.94 Million | -36.98 Million |
| Depreciation & Amortization | 4.14 Million | 4.09 Million | 3.88 Million | 3.75 Million | 13.65 Million | 3.38 Million |
| Deferred income taxes | -930 Thousand | - | 930 Thousand | -8.88 Million | -59.36 Million | - |
| Stock-based compensation | 8.75 Million | 8.84 Million | 7.82 Million | 8.02 Million | 33.67 Million | 8.44 Million |
| Change in working capital | -2.7 Million | -5.93 Million | -10.21 Million | 53.88 Million | 20.12 Million | -14.78 Million |
| Other non-cash items | -3.42 Million | 17.4 Million | -2.86 Million | 6.93 Million | 54.5 Million | -1.19 Million |
| Investing Cash Flow | -21.33 Million | -131.07 Million | 35.51 Million | -14.37 Million | 68.3 Million | 22.77 Million |
| Investments in PPE | -2.34 Million | -1.93 Million | -2.88 Million | -2.58 Million | -8.4 Million | -2.45 Million |
| Acquisitions | 38.39 Million | - | -38.39 Million | 88.49 Million | -76.7 Million | -25.23 Million |
| Investment purchases | -129.81 Million | -225.11 Million | -54.8 Million | -88.39 Million | -246.33 Million | -74.58 Million |
| Sales/Maturities of investments | 110.82 Million | 95.98 Million | 93.2 Million | 76.6 Million | 323.03 Million | 99.82 Million |
| Other Investing Activities | -38.39 Million | -129.13 Million | 38.39 Million | -88.49 Million | 76.7 Million | 25.23 Million |
| Financing Cash Flow | 45.77 Million | 237.75 Million | 1.62 Million | 4.94 Million | 3.21 Million | 1.7 Million |
| Debt repayment | - | - | - | -4.94 Million | - | -4.94 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 15 Thousand | -15 Thousand | - | - | - | - |
| Common Stock Issuance | 41.87 Million | 237.76 Million | 1.62 Million | 7000.00 | 3.21 Million | 1.7 Million |
| Other Financing Activities | 3.89 Million | 237.75 Million | 1.62 Million | 9.88 Million | 3.21 Million | 4.94 Million |
| Accounts receivables | - | - | - | 2 Million | - | -2 Million |
| Accounts payables | 1.09 Million | -2.54 Million | -930 Thousand | 4.65 Million | 1.61 Million | -1.19 Million |
| Inventory | - | - | - | -4.88 Million | - | 4.88 Million |
| Other working capital | -3.79 Million | -3.39 Million | -9.28 Million | 52.11 Million | 18.5 Million | -16.46 Million |
| Cash at beginning of period | 117.69 Million | 49.81 Million | 54.62 Million | 42.3 Million | 64.47 Million | 59.85 Million |
| Cash at end of period | 99.94 Million | 116.79 Million | 49.81 Million | 54.62 Million | 54.62 Million | 43.2 Million |
| Capital Expenditure | -2.34 Million | -1.93 Million | -2.88 Million | -2.58 Million | -8.4 Million | -2.45 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -17.74 Million | 66.97 Million | -4.81 Million | 12.32 Million | -9.84 Million | -16.65 Million |
| Free Cash Flow | -44.52 Million | -41.64 Million | -44.83 Million | 19.16 Million | -89.76 Million | -43.59 Million |
420770
MMM
603699
WLKP
YY
0ILW